Vanguard Personalized Indexing Management LLC, a prominent investment firm, has made headlines with its recent acquisition of shares in Sabra Health Care REIT, Inc. This move reflects Vanguard’s continued interest in the real estate investment trust (REIT) sector and highlights the potential value they see in Sabra’s stock.
According to Vanguard’s 13F filing with the Securities and Exchange Commission, the firm purchased 28,394 shares of Sabra Health Care REIT during the first quarter of this year. These shares are valued at approximately $327,000, underscoring Vanguard’s confidence in the long-term prospects of the company.
Sabra Health Care REIT boasts an impressive investment portfolio that includes 392 real estate properties held for investment as of June 30, 2023. Among these assets are skilled nursing/transitional care facilities, senior housing communities (both leased and managed by third-party property managers), behavioral health facilities, specialty hospitals, and various other healthcare facilities. Additionally, Sabra has made strategic investments in loans receivable and preferred equity investments.
Investors will be pleased to know that Sabra recently announced a quarterly dividend. Set to be paid on August 31st, this dividend is set at $0.30 per share for stockholders of record as of August 17th. With an annualized dividend amounting to $1.20 per share and a yield of 9.42%, Sabra Health Care REIT demonstrates its commitment to returning value to its shareholders.
It is important to note the significance of the ex-dividend date — August 16th — as this represents a key milestone for investors seeking to take advantage of this dividend payout. By purchasing shares prior to this date, investors will ensure their eligibility for receiving the upcoming dividend distribution.
Sabra Health Care REIT’s dividend payout ratio is currently -222.22%. While it may seem unusual for a company to have a negative payout ratio, this metric indicates that Sabra is currently reinvesting profits back into the business rather than distributing them as dividends. This reinvestment strategy suggests an intention to foster growth and expand opportunities within the healthcare real estate market.
As we approach the end of August 2023, Vanguard’s acquisition of shares in Sabra Health Care REIT signals a growing interest in the company’s potential. With a diverse investment portfolio and promising dividend prospects, Sabra stands poised for continued success in the ever-evolving healthcare real estate industry. Investors will undoubtedly be paying close attention to future developments at Sabra Health Care REIT as they navigate an exciting and potentially lucrative market.
[bs_slider_forecast ticker=”SBRA”]
Sabra Health Care REIT Gains Attention from Hedge Funds and Institutional Investors
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has seen a number of hedge funds and institutional investors modify their holdings in the company. Landscape Capital Management L.L.C. increased its position in Sabra Health Care REIT by 16.3% during the first quarter, now owning 12,925 shares of the real estate investment trust’s stock worth $149,000. Mitsubishi UFJ Trust & Banking Corp also increased its holdings in Sabra Health Care REIT by 7.0% during the same period, now owning 28,759 shares valued at $331,000.
Principal Financial Group Inc., one of the largest institutional investors in Sabra Health Care REIT, raised its position by 0.7% during the first quarter and now owns over 15 million shares with a value of approximately $180 million. Bank of New York Mellon Corp also lifted its stake in Sabra Health Care REIT by 14.1%, while US Bancorp DE saw a significant increase of 62.5% in its stake during the first quarter.
These changes highlight the confidence that certain hedge funds and institutional investors have placed in Sabra Health Care REIT and its potential for growth within the real estate investment sector.
NASDAQ: SBRA opened at $12.74 on Thursday and has shown a one year low of $10.08 and a one year high of $15.45. The market cap stands at around $2.95 billion with a P/E ratio of -23.59 and a beta of 1.30.
Sabra Health Care REIT’s investment portfolio as of June 30, 2023 includes a diverse range of real estate properties consisting of skilled nursing/transitional care facilities, senior housing communities (both leased and managed), behavioral health facilities, specialty hospitals, and other facilities.
Research firms have recently provided mixed outlooks on Sabra’s stock. Stifel Nicolaus reduced their price objective from $15.00 to $14.00, while StockNews.com issued a “hold” rating for the stock. Berenberg Bank and Citigroup also gave a “hold” rating, with target prices of $13.00 and $12.50 respectively.
Despite varying opinions, Sabra Health Care REIT currently holds a consensus rating of “Hold” according to Bloomberg.com’s data, with an average price target of $12.94.
In conclusion, Sabra Health Care REIT has attracted attention from hedge funds and institutional investors due to its growth potential in the real estate investment sector. With a diverse portfolio of properties and mixed ratings from research firms, it will be interesting to see how the company continues to perform in the coming months. Investors should carefully consider these factors before making any decisions related to Sabra Health Care REIT’s stock.
